Call for Abstract

11th World Congress on Bioavailability and Bioequivalence, will be organized around the theme “The rationale of BABE studies for Pharmaceutical business and Public health BABE 2020”

BABE 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in BABE 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Drug Safety and Efficacy
  • Track 1-2Dose-Response
  • Track 1-3Clinical Trial Formulations
  • Track 4-1Drug Regulations and Organization
  • Track 4-2Global Pharma Products Registration
  • Track 4-3Reporting of ADR
  • Track 5-1Innovative Strategies of Drug Design & Development
  • Track 5-2Synthesis in Drug Discovery
  • Track 5-3Pharmacogenetics in Drug Discovery
  • Track 5-4Stages of Drug Discovery
  • Track 6-1Pharmaceutical Research
  • Track 6-2Biopharmaceutics
  • Track 6-3Pharmaceutical Microbiology
  • Track 7-1Relative Bioavailability
  • Track 7-2Factors Influencing Bioavailability
  • Track 7-3Hepatic First-Pass Effect
  • Track 8-1Bioequivalence Assessment
  • Track 8-2Bioequivalence of Endogenous Substances
  • Track 8-3In vitro Bioequivalence
  • Track 9-1Biosimilars Development
  • Track 9-2Biosimilars in Therapeutics
  • Track 9-3Clinical Trials of Biosimilars
  • Track 9-4Biosimilars Pipeline
  • Track 10-1Reverse Pharmacology
  • Track 10-2Clinical Efficacy and Safety Evaluation
  • Track 10-3Drug Interactions and Pharmacological Compatibilities